ECI is a biopharma company dedicated to the development, commercialization, and marketing of specialty human plasma/serum-derived drugs for ophthalmic conditions; wound healing; and burns. Leveraging a novel molecule to enhance consistency, and decrease the risk of pathogenicity, ECI seeks to harnes... Read more